Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT01481168
Eligibility Criteria:
Inclusion Criteria:
* Episode of syncope
* Patient has provided written informed consent for participation in the study prior to any study specific procedures
* Male or female
* Age \> 40 years
* No cause of syncope clearly identified on clinical examination, lying and standing blood pressure measurements and standard 12 lead ECG.
Exclusion Criteria:
* Asthma or chronic obstructive pulmonary disease
* Severe coronary disease (myocardial infarction within 3 months, known coronary stenosis \>70%, NYHA heart failure or angina symptoms Class III or IV)
* Known severe cerebrovascular disease or known significant internal carotid artery stenosis (\>70%)
* Prolonged corrected QT interval
* Unablated accessory pathway
* Pregnancy or lactation
* Use of dipyridamole or any rate-limiting medication that cannot be safely discontinued
* Hypertrophic cardiomyopathy
* Cardiac transplantation
* Concurrent participation in another investigational study or trial
* Inability to give informed consent; carer/proxy assent will be allowed in this study
* Cause of syncope established from initial clinical history and examination, lying and standing blood pressure and ECG
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT01481168
Study Brief:
Protocol Section:
NCT01481168